NL7212595A - - Google Patents

Info

Publication number
NL7212595A
NL7212595A NL7212595A NL7212595A NL7212595A NL 7212595 A NL7212595 A NL 7212595A NL 7212595 A NL7212595 A NL 7212595A NL 7212595 A NL7212595 A NL 7212595A NL 7212595 A NL7212595 A NL 7212595A
Authority
NL
Netherlands
Application number
NL7212595A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7212595A publication Critical patent/NL7212595A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
NL7212595A 1971-09-17 1972-09-15 NL7212595A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2147309A DE2147309A1 (de) 1971-09-17 1971-09-17 Arzneimittel auf basis von dehydroepiandrosteronestern

Publications (1)

Publication Number Publication Date
NL7212595A true NL7212595A (fr) 1973-03-20

Family

ID=5820276

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7212595A NL7212595A (fr) 1971-09-17 1972-09-15

Country Status (4)

Country Link
BE (1) BE788897A (fr)
DE (1) DE2147309A1 (fr)
NL (1) NL7212595A (fr)
ZA (1) ZA726325B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19618778A1 (de) * 1995-05-12 1997-01-23 Stefan Dr Schulz Verwendung von Dehydroepiandrosteron und Derivaten hiervon
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy

Also Published As

Publication number Publication date
DE2147309A1 (de) 1973-03-22
BE788897A (fr) 1973-03-15
ZA726325B (en) 1973-06-27

Similar Documents

Publication Publication Date Title
ATA136472A (fr)
AR196074A1 (fr)
AU2658571A (fr)
AU2691671A (fr)
AU2485671A (fr)
AU2684071A (fr)
AU2564071A (fr)
AU2503871A (fr)
AU2836771A (fr)
AU2415871A (fr)
AU2455871A (fr)
AU2837671A (fr)
AU2456871A (fr)
AU2473671A (fr)
AU2724971A (fr)
AU2399971A (fr)
AU2706571A (fr)
AU3038671A (fr)
AU2654071A (fr)
AR192311Q (fr)
AU2854371A (fr)
AU2486471A (fr)
AU2938071A (fr)
AU2669471A (fr)
AU2684171A (fr)